USE OF MIFEPRISTONE AND MISOPROSTOL COMBINATION ON ABORTION IN FIRST TRIMESTER PREGNANCY AT GOVERNMENT HOSPITAL IN CHITWAN DISTRICT IN NEPAL
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2015, Vol 6, Issue 6
Abstract
The present study is a prospective study and was aimed to identify the type and pattern of side effects during and after a medical abortion using a combination therapy of Mifepristone and Misoprostol, association between gestational age and success rate, and its efficacy. Assessment on acceptability, women’s perceptions towards medical abortion, and reasons for abortion were also performed. The study was carried out in 500 beded government hospital in Chitwan district in Nepal. The women (n=85) with a gestational history of less than 59 days were enrolled. The regimen used was oral Mifepristone 200 mg followed by sublingual Misoprostol 800 mcg after 24 hours of Mifepristone administration. The women’s profile form was used as a major data collection tool. Side effect sheet (typed in Nepali language for convenience) to be filled by the women undergoing medical termination of pregnancy (MTP) was issued, which was later submitted to us at the time of their follow-up visit. On follow-up, a pre-tested questionnaire was administered to determine perception and acceptability of MTP. The success rate was found to be 97.6%. Side effects recorded were vaginal bleeding, uterine cramping, abdominal pain, nausea, vomiting, headache, loss of appetite, and sleeplessness. There was a significant association between gestational age and success rate with P value of 0.003. The women provided different reasons for abortion and had a positive attitude towards MTP. In conclusion; the combination of oral Mifepristone and sublingual Misoprostol for medical abortion was found to be efficacious and sublingual administration of Misoprostol has a number of benefits over other routes (vaginal and oral) which could be further studied over a large population in future.
Authors and Affiliations
Kailash Thapaliya , Parbati Thapa
Keywords
Related Articles
- EP ID EP122186
- DOI 10.7897/2230-8407.06674
- Views 99
- Downloads 0
AYURVEDIC MANAGEMENT OF CEREBRAL PALSY: REPORT OF TWO CASES WITH REVIEW OF LITERATURE
Cerebral palsy (CP) is a common cause of childhood disability. It is defined as ‘a group of non progressive but often changing motor impairment syndromes which are secondary to anomalies or lesions of brain arising in ea...
CENTRAL ANTINOCICEPTIVE EFFECT OF DIFFERENT EXTRACTS OF SARACA ASOCA SEEDS ASSESSED USING HOTPLATE AND TAIL IMMERSION METHODS
The stem bark of Ashoka (Saraca asoca) plant has been traditionally used for a number of therapeutic purposes including anti-inflammatory activities. It has been described in ancient Ayurvedic texts as an analgesic also...
FACTORS AFFECTING PHARMACOKINETIC DISPOSITION OF DRUGS
Absorption of drugs from the gastrointestinal tract is a complex process the variability of which is influenced by many physicochemical and physiologic factors. The two most important physicochemical factors that affect...
COLEUS (PLECTRANTHUS BARBATUS) – A MULTIPURPOSE MEDICINAL HERB
Plectranthus barbatus Andr. (Syn. Coleus forskohlii Briq.) is a perennial herb, belonging to the family Lamiaceae. Its tuberous roots are found to be a rich source of forskohlin (coleonol) used as a potential drug for hy...
FORMULATION AND IN-VITRO EVALUATION OF TRANSDERMAL FILMS OF AN ANTI HYPERTENSIVE DRUG
In the present study was made to develop a suitable matrix type transdermal patch of Candesartan Cilexetil, using blends of two different types of polymeric combinations viz. HPMC K100 and Eudragit RL100 prepared formul...